Brief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
30/09/2026 24:52
BRIEF-Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration Sept 30 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX:
INITIATES VOLUNTARY ADMINISTRATION PROCESS
BOARD INTENDS TO DEVELOP PROPOSAL FOR DEED OF COMPANY ARRANGEMENT
SECURITIES REMAIN SUSPENDED FROM TRADING ON ASX DURING ADMINISTRATION
CLINICAL REVIEW AND RESTRUCTURING PROCESS EXPECTED TO TAKE AT LEAST EIGHT WEEKS
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt